Wellsmont Group

About the Wellsmont Group

Who We Are

Our Approach

Consulting Services

Contact

Douglas P. Malinowski- Selected Publications

The Douglas P. Malinowski Publications is a selected list of publications in the peer-reviewed literature that is focused on cancer research. The citations are noted from PubMed:

  1. Douglas P. Malinowski (2005). Molecular diagnostic assays for cervical neoplasia: emerging markers for the detection of high-grade cervical disease. BioTechniques. Supplement on Biomarkers in Cancer Research. 38; S17-S23 (April 2005).
  2. Malinowski DP. Multiple biomarkers in molecular oncology. I. Molecular diagnostics applications in cervical cancer detection. Expert Rev Mol Diagn. 2007 Mar;7(2):117-31.
  3. Malinowski DP. Multiple biomarkers in molecular oncology. II. Molecular diagnostics application in breast cancer management. Expert Rev Mol Diagn. 2007 May;7(3):269-80.
  4. Laura J. Havrilesky, Clark M. Whitehead, Jennifer M. Rubatt, Robert L. Cheek, John Groelke, Qin He, Douglas P. Malinowski, Timothy J. Fischer, Andrew Berchuck. Evaluation of biomarker panels for early-stage ovarian cancer detection and monitoring for disease recurrence. Gynecol Oncol. 2008 Sep;110(3):374-82.
  5. Dixon EP, King LM, Adams MD, Grønn P, Murphy PG, Brown CA, Brough GH, Skomedal H, Malinowski DP, Fischer TJ. Isolation of RNA from residual BD SurePath liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the PreTect HPV-Proofer assay. J Virol Methods. 2008 Dec;154(1-2):220-2. Epub 2008 Sep 20.
  6. Murphy PG, Henderson DT, Adams MD, Horlick EA, Dixon EP, King LM, Avissar PL,
    Brown CA, Fischer TJ, Malinowski DP. Isolation of RNA from cell lines and cervical cytology specimens stored in BD SurePath preservative fluid and downstream detection of housekeeping gene and HPV E6 expression using real time RT-PCR. J Virol Methods. 2009 Mar;156(1-2):138-44. Epub 2009 Jan 3.
  7. Dehn D, Taylor A, Fischer TJ, Malinowski DP, Shroyer KR. Screening for molecular markers of cervical papillomavirus infection: overview of methods and their clinical implications. Methods Mol Biol. 2009; 511:297-310.
  8. Avissar P, Malinowski DP. Detection and genotyping analysis of human papillomavirus isolates from liquid-based cervical cytology specimens. Methods Mol Biol. 2009; 511:361-70.
  9. Dixon EP, Lenz KL, Doobay H, Brown CA, Malinowski DP, Fischer TJ. Recovery of DNA from BD SurePath cytology specimens and compatibility with the Roche AMPLICOR Human Papillomavirus (HPV) Test. J Clin Virol. 2010 May;48(1):31-5.
  10. Henderson D, Hall L, Prpic N, Hessling J, Parker M, Sampson S, Simkins S, Brough G, Dixon E, Lenz K, Knapp S, Murphy P, Taylor A, Fischer T, Malinowski DP. The selection and characterization of antibodies to minichromosome maintenance proteins that highlight cervical dysplasia. J Immunol Methods. 2011; 370 (1-2): 1-13.
  11. Brown CA, Bogers J, Sahebali S, Depuydt CE, De Prins F, Malinowski DP. Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs. J Oncol. 2012; 2012:289315.
  12. Dixon EP, Grønn P, King LM, Passineau H, Doobay H, Skomedal H, Hariri J, Hay SN, Brown CA, Fischer TJ, Malinowski DP. Analytical performance of RNA isolated from BD SurePath™ cervical cytology specimens by the PreTec HPV-Proofer assay. J Virol Methods. 2012 Nov;185(2):199-203.
  13. Dixon EP, King LM, Nelson R, Simkins SG, Knapp SL, Brough GH, Lenz KL, Henderson DT, Whitehead CM, Hessling J, Brown CA, Malinowski DP. Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue. J Immunol Methods. 2017 Mar; 442:35-41. doi: 10.1016/j.jim.2017.01.002. Epub 2017 Jan 16. PMID: 28093271.
  14. Park CK, Malinowski DP, Cho NH. Diagnostic algorithm for determining primary tumor sites using peritoneal fluid. PLoS One. 2018 Jul 19;13(7): e0199715. doi: 10.1371/journal.pone.0199715. PMID: 30024911; PMCID: PMC6053134.
  15. Vaughan LM, Malinowski DP. Comments on: Limitations of HPV DNA Testing in Screening of Cervical Adenocarcinomas. Rev Bras Ginecol Obstet. 2019 May;41(5):357-359. doi: 10.1055/s-0039-1688710. Epub 2019 Jun 10. PMID: 31181587.
  16. Malinowski DP, Broache M, Vaughan L, Andrews J, Gary D, Kaufman HW, Alagia DP, Chen Z, Onisko A, Austin RM. Cotesting in Cervical Cancer Screening. Am J Clin Pathol. 2021 Jan 4;155(1):150-154. doi: 10.1093/ajcp/aqaa169. PMID: 33270087; PMCID: PMC8204934.
  17. Masud SF, Mark N, Goss T, Malinowski D, Schnitt SJ, Sparano JA, Donovan MJ. U.S. payer budget impact of using an AI-augmented cancer risk discrimination digital histopathology platform to identify high-risk of recurrence in women with early-stage invasive breast cancer. J Med Econ. 2024 Jan-Dec;27(1):972-981. doi: 10.1080/13696998.2024.2379211. Epub 2024 Jul 25. Erratum in: J Med Econ. 2024 Jan-Dec;27(1):1061-1062. doi: 10.1080/13696998.2024.2389707. PMID: 39010830.
  18. Fernandez G, Zeineh J, Prastawa M, Scott R, Madduri AS, Shtabsky A, Jaffer S, Feliz A, Veremis B, Mejias JC, Charytonowicz E, Gladoun N, Koll G, Cruz K, Malinowski D, Donovan MJ. Analytical Validation of the PreciseDx Digital Prognostic Breast Cancer Test in Early-Stage Breast Cancer. Clin Breast Cancer. 2024 Feb;24(2):93-102.e6. doi: 10.1016/j.clbc.2023.10.008. Epub 2023 Nov 2. PMID: 38114366.
  19. Malinowski DP, Callaghan R, Whitehead C, Nelson R, Allen L, Purnell D, Taylor A, Morel D, Dhewar A, Chai-Hong VS, Giap-Hean G, Tan SY, Tapas S, Andrews J. BD SurePath Direct to Slide (DTS) cervical cytology: Migrating the benefits of liquid-based cytology to low-resource settings. Am J Clin Pathol. 2024 Jun 24:aqae068. doi: 10.1093/ajcp/aqae068. Epub ahead of print. PMID: 38913880.

A summary of Douglas P. Malinowski’s professional career can be found on the page Who We Are.